IP Library › Granted Patent US 12,274,775
Granted Patent B2
US 12,274,775 · App. 17/428,309 · Granted Apr 15, 2025

Fatty acid esters as anti-

Inventors: Peter Mayser (Biebertal, DE); Manuel Pesaro (Holzminden, DE); Gerhard Schmaus (Höxter, DE); Jessica Grieger (Höxter, DE); Nikolas Bugdahn (Holzminden, DE)
Assignee: SYMRISE AG
A61K8/375A61K8/345A61Q5/006A61Q17/005A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,274,775
App. No.
17/428,309
Granted
Apr 15, 2025
Kind
B2
Abstract

The present invention primarily relates to a fatty acid ester or mixture of two or more fatty acid esters or mixture comprising one or more fatty acid esters, wherein the fatty acid ester or one, two, three or more, preferably all, of the fatty acid ester(s) is/are selected from the group consisting of 3-hydroxypropyl caprylate, glyceryl monocaprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate, for use in the treatment of an excess of Malassezia on the skin surface of mammals, preferably of humans. The present invention further relates to particular mixtures or products, and to the cosmetic, non-therapeutic use of fatty acid esters or of mixtures or products comprising fatty acid esters as defined herein to reduce the amount of Malassezia on the skin surface of mammals, preferably of humans.

Claims (34)

1. An anti-dandruff shampoo comprising:

an amount from 0.3 to 5 wt. %, based on a total weight of the anti-dandruff shampoo, of one or more fatty acid esters selected from 3-hydroxypropyl caprylate, 3-hydroxypropyl undecylenate, or a mixture thereof, and

one or more anionic surfactants selected from sodium laureth sulfate, sodium lauryl sulfate, sodium lauryl sulfoacetate, disodium lauryl sulfosuccinate, sodium olefin C14-C16 sulfonate, sodium oleoyl sarcosinate, disodium sulfoacetate, sodium oleate, sodium sulfate, and sodium cocoyl isethionate,

provided the anti-dandruff shampoo reduces Malassezia and/or treats dandruff.

2. The anti-dandruff shampoo of claim 1 , further comprising:

1,2-pentanediol and 3-hydroxypropyl caprylate,

1,2-pentanediol and 3-hydroxypropyl undecylenate,

1,2-hexanediol and 3-hydroxypropyl caprylate,

1,2-hexanediol and 3-hydroxypropyl undecylenate,

1,2-octanediol and 3-hydroxypropyl caprylate,

1,2-octanediol and 3-hydroxypropyl undecylenate,

1,2-decanediol and 3-hydroxypropyl caprylate, or

1,2-decanediol and 3-hydroxypropyl undecylenate.

3. The anti-dandruff shampoo of claim 1 comprising both the 3-hydroxypropyl caprylate and the 3-hydroxypropyl undecylenate.

4. The anti-dandruff shampoo of claim 1 , wherein the dandruff is caused by an excess of the Malassezia on the skin.

5. The anti-dandruff shampoo of claim 1 , further comprising one or more 1,2-alkane diol(s).

6. The anti-dandruff shampoo of claim 5 , wherein the one or more 1,2-alkane diol(s) are selected from 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, or mixtures thereof.

7. The anti-dandruff shampoo of claim 1 , wherein the Malassezia is M. furfur, M. pachydermatis, M. sympodialis, M. globosa, M. obtusa, M. restricta, M. slooffiae, M. dermatis, M. japonica, M. nana, M. yamatoensis, M. caprae, M. equina, M. cuniculi, M. brasiliensis, M. psitaci, M. arunalokei , or mixtures thereof.

8. A method for treating dandruff comprising application of the anti-dandruff shampoo of claim 1 to the skin.

9. The method of claim 8 , wherein the anti-dandruff shampoo comprises both the 3-hydroxypropyl caprylate and the 3-hydroxypropyl undecylenate.

10. The method of claim 8 , wherein the anti-dandruff shampoo further comprises one or more 1,2-alkane diols selected from 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, or a mixtures thereof.

11. The anti-dandruff shampoo of claim 1 comprising the 3-hydroxypropyl caprylate.

12. The anti-dandruff shampoo of claim 1 comprising the 3-hydroxypropyl undecylenate.

13. The anti-dandruff shampoo of claim 1 , wherein application of the anti-dandruff shampoo to skin suffering from dandruff visually reduces the dandruff by more than 10%.

14. The anti-dandruff shampoo of claim 1 , wherein application of the anti-dandruff shampoo to skin suffering from excess Malassezia reduces the Malassezia by more than 10%.

15. A skin or hair care product comprising:

an amount from 0.3 to 5 wt. %, based on a total weight of the skin or hair care product, of one or more fatty acid esters selected from 3-hydroxypropyl caprylate, 3-hydroxypropyl undecylenate, or a mixture thereof,

one or more anionic surfactants selected from sodium laureth sulfate, sodium lauryl sulfate, sodium lauryl sulfoacetate, disodium lauryl sulfosuccinate, sodium olefin C14-C16 sulfonate, sodium oleoyl sarcosinate, disodium sulfoacetate, sodium oleate, sodium sulfate, and sodium cocoyl isethionate,

provided the skin or hair care product is an oil-in-water emulsion or a water-in-oil emulsion, and reduces Malassezia and/or treats dandruff.

16. The skin or hair care product of claim 15 , wherein application of the skin or hair care product to skin suffering from dandruff visually reduces the dandruff by more than 10%.

17. The skin or hair care product of claim 15 , wherein application of the skin or hair care product to skin suffering from excess Malassezia reduces the Malassezia by more than 10%.

18. The product of claim 15 comprising the 3-hydroxypropyl caprylate.

19. The product of claim 15 comprising the 3-hydroxypropyl undecylenate.

20. A method for treating dandruff comprising application of the skin or hair care product of claim 15 to the skin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2021
From: MAYSER, PETER; SCHMAUS, GERHARD; GRIEGER, JESSICA; BUGDAHN, NIKOLAS
To: SYMRISE AG
Reel/Frame 058810/0870 →
Continuity (1)
Related Publication 20220142885A1 · May 12, 2022
References Cited (19)
US 20100034761A1 · Fenyvesi · 2010 [cited by examiner]
US 20100215775A1 · Schmaus · 2010 [cited by examiner]
US 20140328953A1 · Kwack et al. · 2014 [cited by applicant]
DE 3314786A1 · 1984 [cited by applicant]
DE 102013009616A1 · 2014 [cited by applicant]
EP 1864657A1 · 2007 [cited by applicant]
EP 1923041A1 · 2008 [cited by applicant]
JP H09110648A · 1997 [cited by applicant]
JP 2002114669A · 2002 [cited by applicant]
KR 20170136478A · 2017 [cited by applicant]
SU 1286204A1 · 1987 [cited by applicant]
WO 2011101239A2 · 2011 [cited by applicant]
WO 2018012021A1 · 2018 [cited by applicant]
WO 2018224413A1 · 2018 [cited by applicant]
International Search Report and Written Opinion issued on Oct. 16, 2019 for corresponding PCT Application No. PCT/EP2019/052576. [cited by applicant]
Indonesian Office Action issued on Apr. 30, 2024 for corresponding ID Application No. P00202106950. [cited by applicant]
Brazilian Office Action issued on Apr. 22, 2024 for corresponding BR Application No. BR 11 2021 015252-0. [cited by applicant]
Colombian Office Action issued on Sep. 23, 2024 for corresponding Colombian Application No. NC2021/0011652. [cited by applicant]
Chinese Office Action issued Jun. 14, 2024 for corresponding Chinese Application No. 201980093959.5. [cited by applicant]